title: Management considerations for a heterozygous protein C deficient patient undergoing open heart surgery with cardiopulmonary bypass.
authors.affiliation: Perfusion Services, Department of Pediatrics, Duke University Medical Center, Durham, NC.
authors.forename: D S
authors.initials: DS
authors.lastname: Lawson
authors.forename: E M
authors.initials: EM
authors.lastname: Darling
authors.forename: R E
authors.initials: RE
authors.lastname: Ware
authors.forename: F H
authors.initials: FH
authors.lastname: Kern
authors.forename: R M
authors.initials: RM
authors.lastname: Ungerleider
authors.forename: I R
authors.initials: IR
authors.lastname: Shearer
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D006348:Cardiac Surgical Procedures / Q000379:methods*; D002315:Cardiopulmonary Bypass; D002648:Child; D006579:Heterozygote; D006801:Humans; D008297:Male; D010952:Plasma Substitutes / Q000627:therapeutic use; D011486:Protein C / Q000235:genetics; D020151:Protein C Deficiency; D012086:Reoperation; D013771:Tetralogy of Fallot / Q000150:complications / Q000601:surgery*; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control*